openPR Logo
Press release

Respiratory Inhalers Market Segments, Key Players Strategies, Analysis and Forecasts Till 2023

01-24-2018 06:55 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future - MRFR

/ PR Agency: Market Research Future - MRFR
Market Research Future - MRFR

Market Research Future - MRFR

The Global Respiratory Inhalers Market report titled “Respiratory Inhalers Market Research Report-Forecast to 2023″ is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. Globally the market for respiratory inhaler is expected to grow at the rate of about 6.1% from 2017 to 2023.

TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/3110 .

Market Research Future published new report, titled “Respiratory Inhalers Market -Research Report: Global Forecast to 2023”.

Global Respiratory Inhaler Market Players:
The major participants of this market are Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd.

“AstraZeneca PLC Announces US FDA Accepts Regulatory Submission for Tagrisso in 1st-Line EGFR-Mutated Non-Small Cell Lung Cancer, Dec-18-17” AstraZeneca announced that the US Food and Drug Administration has accepted a supplemental New Drug Application for the use of Tagrisso (osimertinib), a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with clinical activity against central nervous system (CNS) metastases, in the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have EGFR mutations (exon 19 deletions or exon 21 (L858R) substitution mutations).

“Adherium Limited Announces Earnings Results for the First Quarter Ended September 30, 2017; Provides Revenue Guidance for the Full Year Fiscal 2018” Adherium Limited announced earnings results for the first quarter ended September 30, 2017. For the quarter, the company reported total operating cash outflows of AUD 4.0 million against AUD 2.8 million a year ago. Revenues for the quarter were AUD 600,000. The company is on track to reach its previously stated full year fiscal 2018 guidance of revenue in the range of AUD 5.7 million to AUD 7 million.

“Boehringer Ingelheim Presents at New England Venture Summit 2017, Dec-06-2017.” Venue: Lombardo’s Conference Center, 6 Billings Street, Boston, Massachusetts, United States. Speakers: Martin Heidecker.

Market Highlights of Global Respiratory Inhalers Market:
The global respiratory inhaler market has been evaluated as steadily growing market and expected that the market will reach high growth figures. Respiratory inhalers are the devices which are used to control the respiratory conditions by directly inhaling the drug into the respiratory tract. Over the past 50 years, inhaler devices have revolutionized the respiratory care by delivering the medicines directly into the lungs and avoiding the adverse effects caused by the other modes of medication. However there has been a point of concern for the doctors whether the patients are talking the medication correctly or not. Because, even if you have the most potent drug in the inhaler; if the patient does not take the medication correctly and on time, you will not see the desired effect of the drug. Different inhaler drugs are being developed for the different conditions and the inhalers are prescribed to the patients on the basis of the condition of the patient and the severity of the disease. There are some major factors that are driving the market growth such as rising prevalence of respiratory disorders due to increase pollution and unhealthy lifestyle, increasing usage of combination therapies due to associated benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies associated with them and others.

On the other hand, there are some hindering factors which are restricting the market growth such as side effects and complications during inhalation, high prices of devices, and lack of accuracy etc. The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy. However, some of the challenges which the market is expected to face includes competition from new entrants or big pharmaceutical giants entering the business or market and the continuous advancements in the product.

ACCESS COMPLETE REPORT @ https://www.marketresearchfuture.com/reports/respiratory-inhalers-market-3110 .

Regional Analysis of Global Respiratory Inhalers Market:
Depending on geographic region, Respiratory Inhaler market is segmented into four key regions: North America, Europe, Asia Pacific, and Middle East & Africa. Globally North America is the largest market for Respiratory Inhalers. The North America market for Respiratory Inhalers is expected to reach at USD 11,949.4 million by the end of the forecasted period. Europe is the second-largest market for respiratory inhalers which is expected to grow at a CAGR of 6.4%. Asia pacific region is expected to be fastest growing region in respiratory Inhaler market. Middle East & Africa is expected to have limited but steady growth in the market.

Market Segmentation:
Respiratory Inhalers market has been segmented on the basis of type which comprises of manually operated, digitally operated. Manually operated inhalers accounted for the largest market share of the total market in 2016. On the basis of product, the market is segmented into dry powder inhaler, metered dose inhaler, and others. Dry powder inhalers accounted for the largest market share in 2016. On the basis of application, market is segmented into asthma, COPD, and other. Asthma segment accounted for the largest market share of the total market in 2016. On the basis of end user, market is segmented into hospitals & clinics, respiratory care center, and other. Hospitals & clinics dominated the global market with the largest market share of the total market in 2016.

MAJOR TABLE OF CONTENTS:
Chapter 1. Report Prologue

Chapter 2. Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Respiratory Inhalers Market, By Type

Chapter 7. Global Respiratory Inhalers Market, By Product

Chapter 8. Global Respiratory Inhalers Market, By Application

Chapter 9. Global Respiratory Inhalers Market, By End User

Chapter 10. Global Respiratory Inhalers Market, By Region

Chapter 11. Competitive Landscape

Chapter 12. Company Profiles

Chapter 13. LIST OF TABLES:
TABLE 1 Global Respiratory Inhalers Market, By Type, 2014-2023 (USD Million)
TABLE 2 Global Manually Operated Inhaler Market, By Region, 2014-2023 (USD Million)
TABLE 3 Global Digitally Operated Inhaler Market, By Region, 2014-2023 (USD Million)
TABLE 4 Global Respiratory Inhalers Market, By Product, 2014-2023 (USD Million)
TABLE 5 Global Dry Powder Inhaler Market, By Region, 2014-2023 (USD Million)

Chapter 14. LIST OF FIGURES:
FIGURE 1 Global Respiratory Inhaler Market Share, By Type, 2016 (%)
FIGURE 2 Global Respiratory Inhaler Market Share, By Product, 2016 (%)
FIGURE 3 Global Respiratory Inhaler Market Share, By Application, 2016 (%)
FIGURE 4 Global Respiratory Inhaler Market Share, By End User, 2016 (%)
FIGURE 5 Global Respiratory Inhaler Market Share, By Region, 2016 (%)

…CONTINUED

AVAIL DISCOUNT @ https://www.marketresearchfuture.com/check-discount/3110.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Inhalers Market Segments, Key Players Strategies, Analysis and Forecasts Till 2023 here

News-ID: 916127 • Views:

More Releases from Market Research Future - MRFR

Humic Acid Market Expected to Hit USD 1.14 Billion by 2032 with a Remarkable 10.69% CAGR
Humic Acid Market Expected to Hit USD 1.14 Billion by 2032 with a Remarkable 10. …
Humic acid is an organic substance formed through the natural decomposition of plant and animal matter in the soil. It is a key component of humic substances, which also include fulvic acid and humin. Known for its ability to improve soil fertility, enhance nutrient uptake, and stimulate plant growth, humic acid has become an essential input in modern agriculture. Beyond agriculture, it finds applications in horticulture, dietary supplements, animal feed,
Caustic Soda Market Poised to Growth USD 77.98 Billion by 2032 with Thriving CAGR of 6.10%
Caustic Soda Market Poised to Growth USD 77.98 Billion by 2032 with Thriving CAG …
Caustic soda, also known as sodium hydroxide (NaOH), is one of the most widely used industrial chemicals in the world. It is a strong alkali with highly corrosive properties, commonly produced via the chlor-alkali process along with chlorine and hydrogen as co-products. Caustic soda plays a vital role across multiple industries, including pulp and paper, textiles, alumina refining, soaps and detergents, water treatment, food processing, and chemicals manufacturing. The global caustic
Trenchless Pipe Relining Market Set to Grow at an Impressive CAGR of 12.9% Through 2034 | USD 342.15 Billion
Trenchless Pipe Relining Market Set to Grow at an Impressive CAGR of 12.9% Throu …
Trenchless pipe relining is an advanced method of repairing and rehabilitating existing pipelines without the need for extensive excavation. It involves inserting a liner coated with resin into a damaged or corroded pipe, curing it in place, and forming a new structural lining that restores functionality and extends the pipe's service life. This technology has gained significant traction as an efficient, cost-effective, and environmentally friendly alternative to traditional open-cut pipe
Explosives Market Set to Reach USD 40.2 Billion, with a Healthy 2.13% CAGR Till Forecasts 2035
Explosives Market Set to Reach USD 40.2 Billion, with a Healthy 2.13% CAGR Till …
The explosives market encompasses the production, distribution, and application of energetic materials used across a wide range of sectors - from mining, quarrying, and construction to defense, demolition, and special industrial applications. Explosives are engineered formulations designed to release energy rapidly and are typically classified by sensitivity, velocity of detonation, and intended use. While military applications attract attention for their strategic importance, commercial explosives for mining and infrastructure development constitute

All 5 Releases


More Releases for Inhaler

12-09-2024 | Health & Medicine
Getnews
Z!NGHA Introduces Dual-Chamber Aromatherapy Nasal Inhaler
Image: https://www.getnews.info/uploads/e696f4bdf98524eaf4f4f4bc89f2369f.jpg Miami, FL - December 09, 2024 - Z!NGHA, a new player in the wellness space, is thrilled to announce the launch of its flagship product, the Z!NGHA Double Nasal Inhaler, an innovation that combines the therapeutic benefits of aromatherapy and essential oils with the on-the-go convenience of a dual-chamber nasal inhaler. Unlike the industry standard single chamber nasal inahlers, Z!ngha offers simultaneous inhalation through both nostrils, redefining aromatherapy for
Asthma Inhaler Device Market By Type (Metered-dose inhaler, MDI with a spacer, D …
The Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. The research report on the market for asthma inhaler devices offers analysis and insights into the numerous aspects that are anticipated to be present over the course of the forecast period as well as
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma
Oxygen Inhaler Market Size, Share, Growth & Forecast 2026
Global Oxygen Inhaler Market report focuses on Oxygen Inhaler volume and value at global level, regional level and company level. From a global perspective, this report represents the overall Oxygen Inhaler market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and